Diego Arango Del Corro
Grado: Doctor/a
darango(ELIMINAR)@irblleida.cat
ResearcherID: http://www.researcherid.com/rid/M-5667-2016
Grupos
Publicaciones
-
Luk, IY; Mooi, JK; Mouradov, D; Tan, T; Scott, CM; Chionh, F; Jenkins, LJ; Reehorst, CM; Nightingale, R; Savas, P; Tse, JWT; LI Crake, R; Batlle, E; Arango, D; Dopeso, H; Gibbs, P; Tebbutt, NC; Luwor, RB; Scott, AM; Basheer, F; Dhillon, AS; Clemons, NJ; Williams, DS; Firestein, R; Sieber, OM; Mariadason, JM
Model systems and unique biological features of high and low-grade colorectal cancer (CRC) revealed by xenografting 84 human CRC cell lines
Communications Biology 8 875-875. .
-
Dopeso, H; Rodrigues, P; Cartón-García, F; Macaya, I; Bilic, J; Anguita, E; Jing, L; Brotons, B; Vivancos, N; Beà, L; Sánchez-Martín, M; Landolfi, S; Hernandez-Losa, J; Cajal, SRY; Nieto, R; Vicario, M; Farre, R; Schwartz, S Jr; van Ijzendoorn, SCD; Kobayashi, K; Martinez-Barriocanal, A; Arango, D
RhoA downregulation in the murine intestinal epithelium results in chronic Wnt activation and increased tumorigenesis
iScience 27 109400-109400. .
-
Matos, AI; Peres, C; Carreira, B; Moura, LIF; Acurcio, RC; Vogel, T; Wegener, E; Ribeiro, F; Afonso, MB; Santos, FMF; Martínez-Barriocanal, A; Arango, D; Viana, AS; Góis, PMP; Silva, LC; Rodrigues, CMP; Graca, L; Jordan, R; Satchi-Fainaro, R; Florindo, HF
Polyoxazoline-Based Nanovaccine Synergizes with Tumor-Associated Macrophage Targeting and Anti-PD-1 Immunotherapy against Solid Tumors
Advanced Science 10 -. .
-
González-Callejo P; Gener P; Díaz-Riascos ZV; Conti S; Cámara-Sánchez P; Riera R; Mancilla S; García-Gabilondo M; Peg V; Arango D; Rosell A; Labernadie A; Trepat X; Albertazzi L; Schwartz S Jr; Seras-Franzoso J; Abasolo I
Extracellular vesicles secreted by triple negative breast cancer stem cells trigger pre-metastatic niche remodeling and metastatic growth in the lungs.
INTERNATIONAL JOURNAL OF CANCER 152 2153-2165. .
-
Rafael D; Guerrero M; Marican A; Arango D; Sarmento B; Ferrer R; Durán-Lara EF; Clark SJ; Schwartz S Jr
Delivery Systems in Ocular Retinopathies: The Promising Future of Intravitreal Hydrogels as Sustained-Release Scaffolds.
Pharmaceutics 15 -. .
-
Tögel L; Nightingale R; Wu R; Chüeh AC; Al-Obaidi S; Luk I; Dávalos-Salas M; Chionh F; Murone C; Buchanan DD; Chatterton Z; Sieber OM; Arango D; Tebbutt NC; Williams D; Dhillon AS; Mariadason JM
Author Correction: DUSP5 is methylated in CIMP-high colorectal cancer but is not a major regulator of intestinal cell proliferation and tumorigenesis.
SCIENTIFIC REPORTS 13 2422-2422. .
-
Carton-Garcia, F; Brotons, B; Anguita, E; Dopeso, H; Tarragona, J; Nieto, R; Garcia-Vidal, E; Macaya, I; Zagyva, Z; Dalmau, M; Sanchez-Martin, M; van Ijzendoorn SCD; Landolfi, S; Hernandez-Losa, J; Schwartz S Jr; Matias-Guiu, X; Ramón Y Cajal S; Martinez-Barriocanal, A; Arango, D
Myosin Vb as a tumor suppressor gene in intestinal cancer.
ONCOGENE 41 5279-5288. .
-
Luk IY; Jenkins LJ; Schoffer KL; Ng I; Tse JWT; Mouradov D; Kaczmarczyk S; Nightingale R; Burrows AD; Anderson RL; Arango D; Dopeso H; Croft L; Richardson MF; Sieber OM; Liao Y; Mooi JK; Vukelic N; Reehorst CM; Afshar-Sterle S; Whitehall VLJ; Fennell L; Abud HE; Tebbutt NC; Phillips WA; Williams DS; Shi W; Mielke LA; Ernst M; Dhillon AS; Clemons NJ; Mariadason JM
Epithelial de-differentiation triggered by co-ordinate epigenetic inactivation of the EHF and CDX1 transcription factors drives colorectal cancer progression.
CELL DEATH AND DIFFERENTIATION 29 2288-2302. .
-
Fourniols, T; Maggio, V; Rafael, D; Colaco, A; García Vidal E; Lopes, A; Schwartz, S; Martinez-Barriocanal, A; Preat, V; Arango, D
Colorectal cancer inhibition by BET inhibitor JQ1 is MYC-independent and not improved by nanoencapsulation.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS 171 39-49. .
-
Giralt, I; Gallo-Oller, G; Navarro, N; Zarzosa, P; Pons, G; Magdaleno, A; Segura, MF; Sabado, C; Hladun, R; Arango, D; Sánchez de Toledo J; Moreno, L; Gallego, S; Roma, J
Dickkopf-1 Inhibition Reactivates Wnt/ß-Catenin Signaling in Rhabdomyosarcoma, Induces Myogenic Markers In Vitro and Impairs Tumor Cell Survival In Vivo.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 22 -. .
-
Bazzocco S; Dopeso H; Martínez-Barriocanal Á; Anguita E; Nieto R; Li J; García-Vidal E; Maggio V; Rodrigues P; de Marcondes PG; Schwartz S Jr; Aaltonen LA; Sánchez A; Mariadason JM; Arango D
Identification of ZBTB18 as a novel colorectal tumor suppressor gene through genome-wide promoter hypermethylation analysis.
Clinical Epigenetics 13 88-88. .
-
Andrade F; Rafael D; Vilar-Hernández M; Montero S; Martínez-Trucharte F; Seras-Franzoso J; Díaz-Riascos ZV; Boullosa A; García-Aranda N; Cámara-Sánchez P; Arango D; Nestor M; Abasolo I; Sarmento B; Schwartz S
Polymeric micelles targeted against CD44v6 receptor increase niclosamide efficacy against colorectal cancer stem cells and reduce circulating tumor cells in vivo.
JOURNAL OF CONTROLLED RELEASE 331 198-212. .
Proyectos
- CHEMBAR: Chemopreventive effects of barley-based foods rich
- Towards precision radiotherapy for rectal cancer patients Principal Investigator
- Contratos predoctorales de formación en investigación en salud (PFIS)
- Nueva aproximación terapéutica para el cáncer colorectal.
- EPH Receptor Signaling in Endometrial Cancer
- Antioxidant treatment as a novel therapeutic option for microvillus inclusion disease. ARMED
- Programa d'Impuls al Talent i l'Ocupabilitat (2021-2024)
- Nueva estrategia terapéutica para ael cáncer gástrico basada en la modulación de la señalización de RHOA
- Desarrollo de nanosistemas de marcaje de CXCR4 mediante radiosondas para la imagen molecular de células tumorales y del microambiente tumoral
- Identificación de nuevos biomarcadores de respuesta a los compuestos regorafenib y TAS-102 en pacientes con cáncer colorrectal.
- Targeting tumor microevironment by a translational multivalent nanomedicine: towards an effective anticancer combination immunotherapy
